This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dependence on enabling machines and devices, not elsewhere classified
Z21_DEPENDENCE_ENABL_MACHINES_DEVICES_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
414 |
4. Check minimum number of eventsNone |
414 |
5. Include endpointsNone |
414 |
6. Filter based on genotype QC (FinnGen only) |
414 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Dependence on enabling machines and devices, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 414 | 166 | 248 |
| Unadjusted period prevalence (%) | 0.09 | 0.06 | 0.11 |
| Median age at first event (years) | 54.82 | 50.59 | 57.66 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 374
- Matched controls
- 3748
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z99.2
ICD-10 Finland
Dependence on renal dialysis
+∞
207.0
179
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
192.6
173.0
170
16
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
186.5
169.3
167
16
A11CC03
ATC
alfacalcidol; systemic
145.5
157.8
160
19
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
133.5
120
*
TK800
NOMESCO Finland
Hemodialysis
105.4
132.2
140
21
127
Kela drug reimbursment
Transplant complication
1606.0
123.1
113
*
A12AA04
ATC
calcium carbonate; oral
173.1
118.2
119
10
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
+∞
114.6
104
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
133.8
109.3
113
12
137
Kela drug reimbursment
Uraemia requiring dialysis
663.1
105.1
99
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
97.2
89
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
19.7
92.6
149
121
N18.0
ICD-10 Finland
End-stage renal disease
202.1
91.8
92
6
L04AA06
ATC
mycophenolic acid; systemic
173.2
90.7
92
7
B03XA02
ATC
darbepoetin alfa; parenteral
84.2
86.5
95
15
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
85.8
79
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
125.3
83.1
87
9
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
977.5
82.8
78
*
N18.8
ICD-10 Finland
Other chronic renal failure
43.5
80.8
100
31
B05DA
ATC
Isotonic solutions
453.2
76.7
74
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
311.0
76.5
75
*
B03XA01
ATC
erythropoietin; parenteral
160.7
75.1
77
6
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
41.5
69.7
87
27
Z49.2
ICD-10 Finland
Other dialysis
402.7
67.8
66
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
750.9
66.0
63
*
C03CA01
ATC
furosemide; systemic
7.6
65.9
198
481
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
17.4
64.4
106
83
ZXE10
NOMESCO Finland
More than one and less than three hours
6.4
60.8
238
799
V03AE01
ATC
polystyrene sulfonate; oral
109.8
60.0
64
7
ZXD05
NOMESCO Finland
Urgent procedure
6.4
59.0
214
644
B05DB
ATC
Hypertonic solutions
335.6
58.0
57
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.1
56.2
147
277
L04AD01
ATC
ciclosporin; systemic
50.5
56.1
67
16
H02AB04
ATC
methylprednisolone; systemic
8.7
54.7
133
222
Z3226
NOMESCO Finland
Physiotherapist
6.7
54.0
171
419
ZXE20
NOMESCO Finland
More than three and less than five hours
7.9
53.5
140
261
205
Kela drug reimbursment
Chronic hypertension
6.0
53.0
194
568
Z3231
NOMESCO Finland
Registered nurse
5.5
51.1
215
734
Z3229
NOMESCO Finland
Other healthcare associate professional
8.8
50.5
120
190
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
14.6
49.6
87
76
Z2446
NOMESCO Finland
Social worker
8.7
49.5
118
187
TK820
NOMESCO Finland
Peritoneal dialysis
280.6
49.3
49
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
280.6
49.3
49
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
274.1
48.2
48
*
L04AX01
ATC
azathioprine; systemic
17.3
48.1
78
56
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
+∞
47.9
45
*
Z99.9
ICD-10 Finland
Dependence on unspecified enabling machine and device
+∞
47.9
45
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
52.3
45.5
54
12
L04AA01
ATC
[U] ciclosporin; systemic
60.0
44.9
52
10
196
Kela drug reimbursment
Paricalcitol and cinacalcet
248.2
43.9
44
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.7
43.7
112
195
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
15.1
42.7
73
59
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
7.4
42.4
112
203
H02AB09
ATC
hydrocortisone; systemic
21.4
42.3
63
35
XPX08
NOMESCO Finland
Intraoperative flow measurement
161.2
41.7
43
*
V03AE02
ATC
sevelamer; oral
161.2
41.7
43
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
157.0
40.6
42
*
A41.9
ICD-10 Finland
Sepsis, unspecified
14.1
40.4
71
61
Z49.0
ICD-10 Finland
Preparatory care for dialysis
82.5
39.9
44
6
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
25.1
39.7
56
26
N19
ICD-10 Finland
Unspecified kidney failure
16.1
39.3
65
48
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
63.6
39.3
45
8
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
39.2
37
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
25.0
38.3
54
25
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.8
38.2
161
506
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.1
38.0
102
186
ZX120
NOMESCO Finland
Intravenous
7.5
37.4
96
164
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
36.1
123
303
ZXA00
NOMESCO Finland
Right side
4.6
35.6
158
516
RS221
NOMESCO Finland
NA
23.8
35.0
50
24
602
Kela drug reimbursment
Children's severe malnutrition
33.8
34.8
45
15
R4110
NOMESCO Finland
Physiotherapy
4.3
34.7
167
586
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
102.3
34.4
37
*
KAC00
NOMESCO Finland
Nephrectomy
192.2
34.3
35
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
27.4
33.6
46
19
ZXE00
NOMESCO Finland
One hour or less
3.9
33.6
216
973
R50.9
ICD-10 Finland
Fever, unspecified
4.9
33.0
126
348
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
7.5
32.5
82
134
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.4
32.5
56
45
ZXA05
NOMESCO Finland
Left side
4.4
32.4
147
482
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
17.7
32.3
51
33
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
13.8
31.9
56
47
ZXD10
NOMESCO Finland
Scheduled procedure
3.7
31.7
210
952
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
13.5
31.6
56
48
C08CA02
ATC
felodipine; oral
7.2
31.5
82
140
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
23.0
31.3
45
22
H05BX01
ATC
cinacalcet; oral
174.2
31.2
32
*
WW200
NOMESCO Finland
Immunization
19.0
30.6
47
28
RD210
NOMESCO Finland
NA
13.5
30.6
54
46
V03AE03
ATC
lanthanum carbonate; oral
327.2
30.2
30
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
8.3
30.0
70
101
K65.0
ICD-10 Finland
Acute peritonitis
40.8
29.9
37
10
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
29.7
165
636
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
112.2
29.1
31
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
162.4
29.1
30
*
C08CA01
ATC
amlodipine; oral
3.7
29.0
175
721
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
34.0
28.7
37
12
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
28.4
156
591
RS222
NOMESCO Finland
NA
21.7
28.1
41
21
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
18.5
27.9
43
26
C07AB02
ATC
metoprolol; systemic
4.4
27.5
116
345
XF602
NOMESCO Finland
Bloodpressure monitoring
34.9
27.4
35
11
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.3
27.2
92
217
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
+∞
26.4
25
*
C09AA02
ATC
enalapril; systemic
4.1
26.3
123
401
XF400
NOMESCO Finland
ECG with 12 standard connections
4.2
26.3
119
377
J96.1
ICD-10 Finland
Chronic respiratory failure
16.7
26.2
42
28
N17.9
ICD-10 Finland
Acute renal failure, unspecified
11.6
25.9
49
48
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.5
25.9
84
188
Z2221
NOMESCO Finland
Medical doctor
3.5
25.4
155
626
TPH04
NOMESCO Finland
Cathetrisation of vein
3.9
25.2
125
427
V03AG01
ATC
sodium cellulose phosphate; systemic
266.8
25.0
25
*
321
Kela drug reimbursment
Paricalcitol and cinacalcet
266.8
25.0
25
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
4.5
24.9
100
281
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.1
24.6
71
137
C02AC05
ATC
moxonidine; oral
9.7
24.5
51
60
K06.18
ICD-10 Finland
Another gingival hyperplasia
92.9
24.0
26
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.0
23.9
111
355
NHQ40
NOMESCO Finland
Amputation of toe
20.2
23.5
35
19
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
+∞
23.2
22
*
4AA09
NOMESCO Finland
NA
+∞
23.2
22
*
5AB14
NOMESCO Finland
NA
+∞
23.2
22
*
TK810
NOMESCO Finland
Hemofiltration
69.5
23.1
26
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
5.0
23.1
81
196
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
9.5
22.9
48
57
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
48.2
22.7
27
6
RS220
NOMESCO Finland
NA
21.1
22.6
33
17
R1250
NOMESCO Finland
Evaluation of functional capability
14.4
22.5
38
29
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
122.1
21.8
23
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
22.4
21.6
31
15
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
21.5
135
543
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
16.9
21.5
34
22
Z96.1
ICD-10 Finland
Presence of intraocular lens
21.0
21.2
31
16
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
8.7
21.0
46
59
A06AD11
ATC
lactulose; oral
4.3
21.0
87
248
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.2
21.0
69
155
R4190
NOMESCO Finland
Nutritional therapy
5.8
20.9
62
123
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
61.0
20.1
23
*
J01MA14
ATC
moxifloxacin; systemic
5.6
20.1
62
129
Z99.3
ICD-10 Finland
Dependence on wheelchair
+∞
20.0
19
*
BE00A
NOMESCO Finland
NA
+∞
20.0
19
*
Z94.4
ICD-10 Finland
Liver transplant status
+∞
20.0
19
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
+∞
20.0
19
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.5
19.7
105
370
C02CA01
ATC
prazosin; oral
16.8
19.6
31
20
JDB10
NOMESCO Finland
Percutaneous gastrostomy
19.5
19.4
29
16
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
48.8
19.4
23
5
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
27.8
19.4
26
10
J01MA02
ATC
ciprofloxacin; systemic
2.8
19.3
173
872
M04AA01
ATC
allopurinol; systemic
4.2
19.2
79
222
WX882
NOMESCO Finland
High dependency care
6.0
19.1
55
105
K65.9
ICD-10 Finland
Peritonitis, unspecified
+∞
18.9
18
*
TK823
NOMESCO Finland
Peritoneal permeability analysis
+∞
18.9
18
*
RF420
NOMESCO Finland
NA
25.3
18.9
26
11
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
40.7
18.8
23
6
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
40.7
18.8
23
6
A120_
NOMESCO Finland
NA
105.3
18.7
20
*
A210_
NOMESCO Finland
NA
199.4
18.7
19
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
199.4
18.7
19
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
10.6
18.6
36
37
S97
ICPC
Chronic ulcer skin
7.8
18.4
43
61
WX002
NOMESCO Finland
Sedation and analgesia
3.5
18.3
97
338
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.8
18.3
65
158
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
55.4
18.1
21
*
Z2445
NOMESCO Finland
Psychologist
5.4
18.0
56
117
WX892
NOMESCO Finland
Monitored bed care
5.0
18.0
61
141
Z94.1
ICD-10 Finland
Heart transplant status
+∞
17.8
17
*
FM2CE
NOMESCO Finland
NA
10.9
17.8
34
34
RS340
NOMESCO Finland
NA
99.8
17.7
19
*
RS121
NOMESCO Finland
NA
25.5
17.5
24
10
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
6.8
17.5
45
74
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.2
17.2
56
123
RS314
NOMESCO Finland
NA
52.6
17.1
20
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
3.3
17.1
101
381
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.0
17.0
48
89
ZXA10
NOMESCO Finland
Bilateral
3.3
17.0
100
375
L28
ICPC
Limited function/disability (L)
3.6
16.9
83
271
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
66.4
16.9
19
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
66.4
16.9
19
*
CKC10
NOMESCO Finland
Local photocoagulation of retina
17.3
16.8
26
16
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
5.1
16.8
55
122
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.7
16.7
36
45
WW400
NOMESCO Finland
Plasmaferesis
94.3
16.7
18
*
RF410
NOMESCO Finland
NA
24.4
16.6
23
10
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
16.5
117
498
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.7
16.5
59
144
Z01.8
ICD-10 Finland
Other specified special examinations
3.2
16.4
102
397
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.3
16.3
44
77
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.3
16.3
44
77
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
11.1
16.0
30
29
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
10.4
16.0
31
32
A28
ICPC
Limited function/disability NOS
3.5
15.9
81
272
XA402
NOMESCO Finland
ENMG
12.5
15.8
28
24
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
+∞
15.7
15
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
15.7
15
*
H05BX02
ATC
paricalcitol; systemic
+∞
15.7
15
*
RF120
NOMESCO Finland
NA
23.2
15.7
22
10
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
88.8
15.7
17
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
88.8
15.7
17
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
166.5
15.6
16
*
A41.8
ICD-10 Finland
Other specified sepsis
12.0
15.5
28
25
N02AX02
ATC
tramadol; systemic, rectal
2.6
15.4
158
831
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
24.6
15.3
21
9
N17.8
ICD-10 Finland
Other acute renal failure
24.6
15.3
21
9
SPAT1229
SPAT
Assessment of need for aid
5.0
15.2
50
111
I15.8
ICD-10 Finland
Other secondary hypertension
47.0
15.2
18
*
WX730
NOMESCO Finland
Conventional respirator
15.9
15.1
24
16
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
11.1
15.0
28
27
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
11.1
15.0
28
27
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
8.3
15.0
33
43
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.8
14.9
43
82
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
5.8
14.9
43
82
B01AC04
ATC
clopidogrel; oral
3.4
14.7
77
263
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
+∞
14.7
14
*
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
14.7
14
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
14.7
14
*
K65.8
ICD-10 Finland
Other peritonitis
155.7
14.6
15
*
A220_
NOMESCO Finland
NA
155.7
14.6
15
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
155.7
14.6
15
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
14.5
75
253
RS122
NOMESCO Finland
NA
28.5
14.4
19
7
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.2
14.3
45
95
WX203
NOMESCO Finland
Infraclavicular plexus blockade
12.7
14.3
25
21
JAH00
NOMESCO Finland
Laparotomy
10.0
14.2
28
30
A46
ICD-10 Finland
Erysipelas
3.7
14.2
66
205
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.5
14.1
52
130
NFQ20
NOMESCO Finland
Amputation of femur
31.4
14.0
18
6
IGY02
NOMESCO Finland
Psychiatric monitoring contact
7.1
13.9
34
52
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
55.5
13.9
16
*
A10AE04
ATC
insulin glargine; parenteral
4.3
13.7
53
139
GD1LA
NOMESCO Finland
GD
35.5
13.6
17
5
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
35.5
13.6
17
5
M03BX01
ATC
baclofen; systemic
13.5
13.6
23
18
J01FF01
ATC
clindamycin; systemic
2.6
13.5
117
550
Z71.8
ICD-10 Finland
Other specified counselling
2.7
13.5
113
523
WX202
NOMESCO Finland
Supraclavicular plexus blockade
22.1
13.5
19
9
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.3
13.4
51
132
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.6
13.3
39
76
XA800
NOMESCO Finland
Neuropsychological investigation
4.7
13.3
46
108
ZX199
NOMESCO Finland
Other rote
41.7
13.2
16
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.8
13.2
99
426
WW500
NOMESCO Finland
Blood transfusion
6.6
13.2
34
56
I50.9
ICD-10 Finland
Heart failure, unspecified
3.8
13.2
58
171
RK320
NOMESCO Finland
NA
17.5
13.1
20
12
U14
ICPC
Kidney symptom/complaint
17.5
13.1
20
12
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.1
13.1
42
91
B01AA03
ATC
warfarin; systemic
3.0
13.1
82
317
ZY010
NOMESCO Finland
Hospital outpatient
4.3
13.0
49
126
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
51.9
12.9
15
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
6.2
12.7
34
59
K03.66
ICD-10 Finland
Tooth plaque
3.7
12.7
58
177
RK110
NOMESCO Finland
NA
33.3
12.7
16
5
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.5
12.6
46
114
R5140
NOMESCO Finland
Monitoring the use of the aid
3.8
12.6
55
161
NGQ20
NOMESCO Finland
Amputation of lower leg
25.3
12.6
17
7
RS230
NOMESCO Finland
NA
25.3
12.6
17
7
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
12.4
96
422
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
8.2
12.3
27
35
M01AH05
ATC
etoricoxib; oral
0.4
12.3
63
1287
RD211
NOMESCO Finland
NA
5.7
12.3
35
66
CKC15
NOMESCO Finland
Panretinal photocoagulation
38.9
12.3
15
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.8
12.2
89
377
J01CF02
ATC
cloxacillin; systemic
10.6
12.2
23
23
RS142
NOMESCO Finland
NA
27.7
12.1
16
6
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.7
12.1
54
161
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
22.2
12.1
17
8
B07.9
ICD-10 Finland
Verruca simplex
6.3
12.1
32
55
J01MA12
ATC
levofloxacin; systemic
2.9
12.0
82
333
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
48.3
12.0
14
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.2
11.8
46
122
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
17.1
11.8
18
11
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
7.6
11.7
27
38
RS311
NOMESCO Finland
NA
31.1
11.7
15
5
TJD20
NOMESCO Finland
Change of gastrostomy tube
31.1
11.7
15
5
H26.3
ICD-10 Finland
Drug-induced cataract
67.1
11.7
13
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.6
11.7
55
172
81
HP
Angiography of the heart and coronary arteries
5.7
11.6
33
62
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.0
11.6
70
263
TK822
NOMESCO Finland
Assessment of adequacy of peritoneal dialysis
+∞
11.5
11
*
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
+∞
11.5
11
*
Z43.5
ICD-10 Finland
Attention to cystostomy
123.6
11.5
12
*
TJA30
NOMESCO Finland
Peritoneal dialysis
123.6
11.5
12
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
123.6
11.5
12
*
A02BC01
ATC
omeprazole; systemic
2.4
11.5
112
556
R13
ICD-10 Finland
Dysphagia
5.0
11.5
37
81
RS211
NOMESCO Finland
NA
15.7
11.4
18
12
RS313
NOMESCO Finland
NA
36.2
11.3
14
*
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
17.7
11.3
17
10
E87.5
ICD-10 Finland
Hyperkalaemia
13.3
11.3
19
15
WX204
NOMESCO Finland
Axillary plexus blockaced
7.5
11.2
26
37
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.2
11.2
43
112
N18
ICPC
Paralysis/weakness
11.7
11.2
20
18
H01AC01
ATC
somatropin; parenteral
9.7
11.2
22
24
H3603, E103
ICD-10 Finland
NA
14.5
11.1
18
13
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
14.5
11.1
18
13
M01AE01
ATC
ibuprofen; systemic, rectal
0.5
11.1
178
2458
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
44.7
11.0
13
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.9
10.8
24
32
ZZA00
NOMESCO Finland
Split skin graft
6.7
10.8
27
43
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.1
10.8
43
116
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
18.5
10.8
16
9
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.3
10.8
28
47
G12.2
ICD-10 Finland
Motor neuron disease
29.0
10.8
14
5
ZXC40
NOMESCO Finland
Use of ultrasound
22.2
10.8
15
7
XF600
NOMESCO Finland
Bloodpressure measurement
3.6
10.7
49
149
M10.3
ICD-10 Finland
Gout due to impairment of renal function
61.8
10.7
12
*
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
61.8
10.7
12
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
11.7
10.7
19
17
C07AG02
ATC
carvedilol; oral
4.5
10.6
37
88
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
10.6
60
215
N06AA09
ATC
amitriptyline; systemic
3.8
10.6
45
129
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.1
10.5
23
30
K03.00
ICD-10 Finland
Approximal wear
5.2
10.5
32
66
A123_
NOMESCO Finland
NA
113.0
10.5
11
*
3A013
NOMESCO Finland
NA
+∞
10.5
10
*
A420_
NOMESCO Finland
NA
+∞
10.5
10
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
10.5
10
*
RP120
NOMESCO Finland
NA
+∞
10.5
10
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
16.6
10.4
16
10
ZXE40
NOMESCO Finland
More than seven and less than nine hours
9.2
10.4
21
24
H26.2
ICD-10 Finland
Complicated cataract
24.1
10.3
14
6
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
24.1
10.3
14
6
H26.02
ICD-10 Finland
Presenil cataract
13.6
10.3
17
13
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
8.8
10.2
21
25
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.1
10.2
39
102
TQW11
NOMESCO Finland
Vacuum treatment of wound
11.7
10.2
18
16
N99
ICPC
Neurological disease other
9.5
10.1
20
22
N02AA05
ATC
oxycodone; systemic
2.9
10.1
66
260
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
4.3
10.1
37
93
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
41.2
10.0
12
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
6.0
10.0
27
48
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
10.0
76
327
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
17.3
9.9
15
9
J96.0
ICD-10 Finland
Acute respiratory failure
12.6
9.9
17
14
AN1
HP
Coronary angiography
3.4
9.9
48
153
H43.1
ICD-10 Finland
Vitreous haemorrhage
9.1
9.9
20
23
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
20.7
9.9
14
7
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
20.7
9.9
14
7
A10AA02
ATC
NA
5.9
9.9
27
49
XCK10
NOMESCO Finland
Photography of fundus of eye
3.4
9.8
49
160
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
13.9
9.7
16
12
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
8.2
9.7
21
27
H25.1
ICD-10 Finland
Senile nuclear cataract
2.6
9.7
80
359
RK322
NOMESCO Finland
NA
56.4
9.7
11
*
RJ411
NOMESCO Finland
NA
56.4
9.7
11
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
56.4
9.7
11
*
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
56.4
9.7
11
*
A211_
NOMESCO Finland
NA
56.4
9.7
11
*
N28
ICPC
Limited function/disability (N)
11.8
9.7
17
15
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.0
9.5
57
210
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
9.5
162
1020
RJ414
NOMESCO Finland
NA
102.4
9.5
10
*
3AC01
NOMESCO Finland
NA
30.9
9.5
12
*
WX872
NOMESCO Finland
Intensive care
5.5
9.4
27
52
A221_
NOMESCO Finland
NA
+∞
9.4
9
*
B05XA03
ATC
sodium chloride; parenteral
+∞
9.4
9
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
22.4
9.4
13
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
9.4
156
973
ZYC01
NOMESCO Finland
Remote contact by phone
4.8
9.3
30
66
C08CA05
ATC
nifedipine; systemic
3.6
9.3
41
122
R11
ICD-10 Finland
Nausea and vomiting
3.2
9.2
48
162
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
9.2
44
139
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
9.2
39
112
C02EA02
ATC
NA
4.6
9.2
31
72
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.5
9.1
43
135
A10AA01
ATC
NA
6.4
9.1
23
38
I50.0
ICD-10 Finland
Congestive heart failure
4.5
9.0
31
73
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
4.8
9.0
29
64
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.0
8.9
28
60
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.8
8.9
58
226
C07AB07
ATC
bisoprolol; oral
2.0
8.9
158
1003
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
11.1
8.9
16
15
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
7.5
8.8
20
28
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.6
8.8
68
295
C01DA14
ATC
isosorbide mononitrate; oral
2.9
8.8
57
221
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.5
8.8
75
344
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.8
8.7
36
101
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.9
8.7
35
96
RJ420
NOMESCO Finland
NA
51.2
8.7
10
*
WX610
NOMESCO Finland
Patient controlled analgesia
51.2
8.7
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.7
8.7
37
107
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
12.0
8.6
15
13
N03AX16
ATC
pregabalin; oral
2.4
8.6
79
376
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.9
8.6
35
97
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
6.7
8.6
21
33
RF210
NOMESCO Finland
NA
6.7
8.6
21
33
Z00.0
ICD-10 Finland
General medical examination
2.4
8.6
81
391
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.5
8.5
40
125
R68.8
ICD-10 Finland
Other specified general symptoms and signs
20.6
8.5
12
6
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
20.6
8.5
12
6
I50.1
ICD-10 Finland
Left ventricular failure
5.5
8.5
24
46
A98
ICPC
Health maint/preventive medicine
0.4
8.4
281
3257
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.1
8.4
47
165
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
92.0
8.4
9
*
Z98.8
ICD-10 Finland
Other specified postsurgical states
92.0
8.4
9
*
A08.2
ICD-10 Finland
Adenoviral enteritis
92.0
8.4
9
*
RS223
NOMESCO Finland
NA
92.0
8.4
9
*
RF432
NOMESCO Finland
NA
92.0
8.4
9
*
WZC30
NOMESCO Finland
Teaching
2.7
8.4
60
249
WX402
NOMESCO Finland
General anaesthesia
2.4
8.4
77
365
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
8.4
8
*
783
NOMESCO Finland
NA
+∞
8.4
8
*
BC00A
NOMESCO Finland
NA
+∞
8.4
8
*
A320_
NOMESCO Finland
NA
+∞
8.4
8
*
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
+∞
8.4
8
*
Z93.1
ICD-10 Finland
Gastrostomy status
+∞
8.4
8
*
1AB02
NOMESCO Finland
NA
+∞
8.4
8
*
R5120
NOMESCO Finland
Preparation of an aid
7.3
8.4
19
27
A12BA01
ATC
potassium chloride; oral
4.6
8.3
28
65
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.8
8.3
54
210
Z50.1
ICD-10 Finland
Other physical therapy
4.0
8.2
32
86
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
12.1
8.1
14
12
K03.28
ICD-10 Finland
Other erosion of teeth
17.6
8.1
12
7
H36.00
ICD-10 Finland
Diabetic background retinopathy
9.2
8.1
16
18
RK323
NOMESCO Finland
NA
34.1
8.1
10
*
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
34.1
8.1
10
*
R5599
NOMESCO Finland
Other rehabilitation service
5.8
8.1
22
40
K00.00
ICD-10 Finland
Hypodontia
10.4
8.1
15
15
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
10.4
8.1
15
15
RK220
NOMESCO Finland
NA
22.6
8.1
11
5
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
6.8
8.0
19
29
UKC02
NOMESCO Finland
Cystoscopy
2.4
7.9
70
327
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.6
7.8
34
100
E86
ICD-10 Finland
Volume depletion
6.6
7.8
19
30
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
45.9
7.7
9
*
RS310
NOMESCO Finland
NA
45.9
7.7
9
*
RK321
NOMESCO Finland
NA
45.9
7.7
9
*
A222_
NOMESCO Finland
NA
45.9
7.7
9
*
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
45.9
7.7
9
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
45.9
7.7
9
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.1
7.7
23
47
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
7.7
71
338
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.7
7.7
32
91
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
6.9
7.7
18
27
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.2
7.7
40
136
G04BD04
ATC
oxybutynin; oral, transdermal
4.3
7.7
27
66
TPX15
NOMESCO Finland
Removal of vascular injection port
18.8
7.6
11
6
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
18.8
7.6
11
6
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
18.8
7.6
11
6
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
18.8
7.6
11
6
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
7.6
129
795
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
7.4
7.6
17
24
IEP02
NOMESCO Finland
Child-centred family therapy
7.4
7.6
17
24
CKC12
NOMESCO Finland
Photocoagulation of retina
4.3
7.5
27
67
ZX197
NOMESCO Finland
NA
81.6
7.4
8
*
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
81.6
7.4
8
*
RK120
NOMESCO Finland
NA
81.6
7.4
8
*
A230_
NOMESCO Finland
NA
81.6
7.4
8
*
GBB00
NOMESCO Finland
Tracheostomy
13.7
7.4
12
9
WX212
NOMESCO Finland
Femoral plexus blockade
9.6
7.3
14
15
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
+∞
7.3
7
*
RJ421
NOMESCO Finland
NA
+∞
7.3
7
*
Z93.5
ICD-10 Finland
Cystostomy status
+∞
7.3
7
*
Z43.0
ICD-10 Finland
Attention to tracheostomy
+∞
7.3
7
*
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
+∞
7.3
7
*
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
+∞
7.3
7
*
Q61.41
ICD-10 Finland
Renal dysplasia of both kidneys (multicystic)
+∞
7.3
7
*
B01AB05
ATC
enoxaparin; parenteral
2.1
7.2
95
529
RF430
NOMESCO Finland
NA
30.6
7.2
9
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
30.6
7.2
9
*
G72.9
ICD-10 Finland
Myopathy, unspecified
20.5
7.2
10
5
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
6.2
7.2
18
30
B34.9
ICD-10 Finland
Viral infection, unspecified
4.0
7.1
27
71
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.0
7.1
27
71
R4120
NOMESCO Finland
Occupational therapy
3.1
7.1
37
126
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
10.3
7.1
13
13
P07.3
ICD-10 Finland
Other preterm infants
7.2
7.1
16
23
L03.0
ICD-10 Finland
Cellulitis of finger and toe
3.2
7.1
35
115
M10.9
ICD-10 Finland
Gout, unspecified
3.8
7.0
28
77
C09CA01
ATC
losartan; oral
2.1
7.0
83
442
N05CD07
ATC
temazepam; oral
2.6
7.0
51
214
A10AA03
ATC
NA
14.1
6.9
11
8
WX722
NOMESCO Finland
PEEP
4.0
6.9
26
68
J01CF05
ATC
flucloxacillin; systemic
5.2
6.9
20
40
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
6.9
6.9
16
24
R06.0
ICD-10 Finland
Dyspnoea
2.1
6.9
85
459
K90
ICPC
Stroke/cerebrovascular accident
6.3
6.8
17
28
H3601, E113
ICD-10 Finland
NA
11.2
6.8
12
11
C08DB01
ATC
diltiazem; oral
4.1
6.8
25
64
306
Kela drug reimbursment
Erythropoietin and darbepoetin
40.8
6.8
8
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
17.1
6.8
10
6
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
6.8
62
291
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.2
6.7
33
108
C08CA13
ATC
lercanidipine; oral
2.6
6.7
49
205
AN4
HP
Balloon angioplasty and drug eluding stent
5.7
6.7
18
33
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.8
6.7
42
161
H3603, E113
ICD-10 Finland
NA
12.5
6.6
11
9
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
6.6
96
555
XCD20
NOMESCO Finland
Photoangiography of eye
8.9
6.6
13
15
I25.2
ICD-10 Finland
Old myocardial infarction
3.6
6.6
28
82
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
6.6
123
778
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
6.5
34
116
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
5.5
6.5
18
34
SPAT1252
SPAT
Overall medication plan or its review
3.3
6.5
31
99
AN2
HP
Balloon angioplasty, including several vessels
5.9
6.5
17
30
T89
ICPC
Diabetes insulin dependent
3.8
6.5
26
72
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
7.6
6.5
14
19
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.0
6.5
37
134
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
71.0
6.4
7
*
GBB96
NOMESCO Finland
Other tracheostomy procedure
71.0
6.4
7
*
RK310
NOMESCO Finland
NA
71.0
6.4
7
*
6BA02
NOMESCO Finland
NA
14.6
6.4
10
7
N03AE01
ATC
clonazepam; systemic
3.5
6.4
28
84
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
6.7
6.4
15
23
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
6.7
6.4
15
23
EBA10
NOMESCO Finland
Surgical removal of tooth
2.7
6.4
42
167
C03DA01
ATC
spironolactone; oral
2.8
6.4
40
152
H65.3
ICD-10 Finland
Chronic mucoid otitis media
3.6
6.4
27
79
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
4.5
6.3
21
49
G35
ICD-10 Finland
Multiple sclerosis
9.5
6.3
12
13
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
9.5
6.3
12
13
N30.9
ICD-10 Finland
Cystitis, unspecified
4.1
6.3
23
59
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
18.4
6.3
9
5
I15.0
ICD-10 Finland
Renovascular hypertension
18.4
6.3
9
5
Q62.2
ICD-10 Finland
Congenital megaloureter
+∞
6.3
6
*
TKA05
NOMESCO Finland
Aspiration cytology of kidney
+∞
6.3
6
*
RJ412
NOMESCO Finland
NA
+∞
6.3
6
*
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
+∞
6.3
6
*
PFH66
NOMESCO Finland
Bypass from femoral or popliteal artery to dorsal artery of foot
+∞
6.3
6
*
RJ190
NOMESCO Finland
NA
+∞
6.3
6
*
GBB13
NOMESCO Finland
Revision of tracheostomy
+∞
6.3
6
*
N81
ICPC
Injury nervous system other
+∞
6.3
6
*
TGB20
NOMESCO Finland
Tracheostomy tube replacement
+∞
6.3
6
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
+∞
6.3
6
*
Z93.0
ICD-10 Finland
Tracheostomy status
+∞
6.3
6
*
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
27.1
6.2
8
*
D03BA02
ATC
collagenase; topical
27.1
6.2
8
*
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
27.1
6.2
8
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
27.1
6.2
8
*
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
27.1
6.2
8
*
U29
ICPC
Urinary symptom/complaint other
5.9
6.2
16
28
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.9
6.2
24
65
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.0
6.2
23
60
XCK00
NOMESCO Finland
Perimetry
3.3
6.2
29
92
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.5
6.2
27
81
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
3.4
6.1
28
87
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
12.8
6.1
10
8
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
12.8
6.1
10
8
3AX01
NOMESCO Finland
NA
12.8
6.1
10
8
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.5
6.1
27
82
SPAT1231
SPAT
Assessment of adjustments needed in living environment
6.2
6.1
15
25
SPAT1234
SPAT
Support of social functional capacity
3.6
6.0
25
72
UJF32
NOMESCO Finland
Coloscopy
2.0
6.0
81
452
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
114
81
18.95
129.95
4.2
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
113
80
18.96
129.01
4.1
1.1
u/ml
114.9
92.5
0.82
18
13
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
72
29
29.71
104.25
2.6
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
62
20
36.12
96.27
1.5
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
186
388
7.85
93.91
13.3
2.3
%
23.4
23.2
0.06
179
344
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
62
23
31.38
92.05
3.0
2.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
98
96
13.00
91.15
3.6
1.2
u/ml
245.3
195.8
0.48
74
41
(3000991) Gas panel - Venous blood
185
395
7.62
90.96
30.0
7.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
98
97
12.87
90.50
3.6
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
82
0
+∞
88.66
8.5
0.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
191
437
7.22
87.20
28.0
5.9
mmol/l
0.7
1.5
2.72
175
324
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
160
314
7.64
84.70
23.8
6.7
mmol/l
23.7
23.8
0.05
153
297
(3024928) Oxygen saturation in Venous blood
86
78
13.59
83.76
17.9
11.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
81
80
12.29
74.35
17.8
5.4
u/ml
0.2
0.4
1.77
54
43
(40768446) Kidney Pathology biopsy report
74
9
99.47
68.48
3.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
102
167
7.74
62.57
3.6
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
147
375
5.50
56.67
3.3
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
319
5.64
54.84
5.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
143
372
5.32
53.57
3.1
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
103
201
6.46
52.85
9.9
2.3
ml/min/173m2
39.9
69.0
2.39
67
75
(1616796) Gas panel - Central venous blood
54
48
12.73
52.55
10.1
2.8
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
48
0
+∞
51.02
7.5
0.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
67
87
8.95
49.66
24.2
2.6
mmol/l
22.4
23.9
1.67
67
75
(3042936) Bacteria identified in Isolate by Culture
145
405
4.95
49.43
4.7
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
143
403
4.87
48.06
22.0
7.1
mmol/l
103.1
104.6
2.64
143
395
(3007853) Bacteria identified in Skin by Aerobe culture
137
380
4.87
46.83
4.1
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
135
377
4.81
45.64
4.9
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
209
816
4.13
44.83
10.2
4.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
214
874
3.98
42.50
28.3
3.6
ph
7.4
7.4
2.91
28
139
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
174
620
4.09
42.02
8.2
2.7
e6/l
0.6
0.9
1.12
127
358
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
153
500
4.25
41.64
3.5
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
111
285
4.93
41.27
9.3
3.0
e9/l
62.1
67.0
0.81
91
212
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
59
83
8.09
40.69
3.0
1.8
—
—
—
0
0
(44806118)
48
52
10.26
40.64
3.0
1.4
—
—
—
0
0
(44790047)
48
52
10.26
40.64
3.0
1.4
—
—
—
0
0
(44790048)
48
52
10.26
40.64
3.0
1.4
—
—
—
0
0
(44790049)
48
52
10.26
40.64
3.0
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
58
84
7.83
38.97
3.1
1.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
118
337
4.48
38.11
22.2
6.8
kpa
5.1
5.1
0.41
113
324
(3027801) Oxygen [Partial pressure] in Arterial blood
118
337
4.48
38.11
22.2
6.8
kpa
11.0
13.0
3.32
113
326
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
87
198
5.27
37.06
2.7
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
117
339
4.39
36.99
22.4
6.8
mmol/l
-0.1
0.9
1.48
94
264
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
163
598
3.83
36.98
8.6
2.8
e6/l
2.6
1.7
0.60
112
339
(3037121) Protein [Mass/volume] in Urine
66
117
6.49
36.69
14.2
6.3
g/l
0.6
0.3
1.00
61
60
(3014148) Varicella zoster virus Ab [Titer] in Serum
36
30
12.99
36.17
1.6
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
145
506
3.85
35.17
4.8
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
173
694
3.54
33.72
6.7
2.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
66
127
5.96
33.66
2.7
1.6
g/l
1.4
1.5
0.37
60
112
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
119
374
4.04
33.36
33.6
6.0
mmol/l
1.3
1.0
0.47
93
269
(3016502) Oxygen saturation in Arterial blood
105
304
4.27
32.91
24.9
7.2
%
93.2
95.1
1.06
100
292
(3009343) pH of Capillary blood
119
380
3.97
32.55
34.0
6.0
ph
7.4
7.4
0.58
13
22
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
36
36
10.81
32.09
1.6
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
40
48
9.08
31.21
2.1
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
38
44
9.36
30.45
19.3
18.5
%
11.5
11.9
0.24
38
44
(3017817) Protein [Mass] in Urine collected for unspecified duration
31
27
12.27
30.21
2.0
2.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
42
56
8.20
30.09
2.6
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
205
973
3.17
29.38
13.4
3.0
e6/l
0.3
0.4
0.56
183
729
(40758558) Short blood count panel - Blood
197
915
3.18
29.30
14.0
7.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
170
725
3.26
29.24
9.0
3.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
277
1584
3.24
28.26
62.8
6.9
mmol/l
1.2
1.2
1.36
270
1383
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
91
264
4.12
28.15
7.6
3.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
66
7.12
27.21
2.3
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
199
960
3.05
27.21
12.9
2.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
50
90
6.15
27.15
2.3
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
33
8
44.49
27.14
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
32
8
43.03
26.17
1.0
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
72
188
4.40
25.49
22.2
8.9
%
92.1
94.6
1.56
72
188
(3002582) Erythrocytes [#/volume] in Urine
208
1060
2.92
25.24
15.0
3.1
e6/l
28.0
42.6
0.83
186
814
(40761535) Cells panel - Urine sediment
78
219
4.14
25.07
8.2
3.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
36
9.18
24.70
1.3
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
69
179
4.40
24.60
2.1
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
29
6
51.52
24.56
4.0
3.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
54
7.39
24.45
2.1
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
186
907
2.89
24.30
7.4
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
210
1109
2.80
23.32
19.1
7.4
inr
1.3
1.2
0.66
69
292
(3020717) Zinc [Moles/volume] in Serum or Plasma
25
24
10.97
22.76
2.5
2.4
umol/l
15.8
18.5
0.23
25
24
(3026008) Bacteria identified in Urine by Culture
170
817
2.82
22.47
6.6
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
34
51
7.14
21.89
16.1
2.5
—
—
—
0
0
(4035726)
76
234
3.74
21.28
2.0
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
24
24
10.51
21.23
3.1
3.5
umol/l
30.4
26.0
0.81
24
24
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
217
1214
2.64
20.79
16.0
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
36
61
6.34
20.66
14.9
2.2
—
—
—
0
0
(3026782) Osmolality of Urine
146
673
2.79
20.59
9.6
2.5
mosm/kgh2o
521.9
582.7
3.61
138
563
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
66
190
3.92
20.31
2.7
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
214
1210
2.57
19.75
18.4
3.7
e6/l
111.2
120.3
0.06
189
860
(3001122) Ferritin [Mass/volume] in Serum or Plasma
224
1298
2.56
19.58
12.3
2.7
ug/l
238.1
121.0
7.06
224
1199
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
18
0
+∞
18.86
5.2
0.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
36
67
5.76
18.77
2.2
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
100
399
2.97
18.21
5.6
3.3
umol/l
5.2
9.7
3.01
82
343
(3019060) Gas panel - Arterial blood
62
186
3.73
17.91
22.6
4.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
220
1307
2.44
17.63
9.8
3.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
43
6.88
17.59
2.2
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
85
317
3.10
17.37
36.9
6.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
44
6.72
17.22
1.4
1.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
83
307
3.12
17.19
33.0
6.7
mmol/l
24.1
24.2
0.04
83
298
(3052851) Hemolysis interference index of Serum or Plasma
42
97
4.68
17.16
6.7
3.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
85
4.94
17.07
2.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
85
4.94
17.07
2.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
85
320
3.07
17.07
22.2
19.0
inr
2.2
1.3
—
6
40
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
242
1518
2.41
16.92
11.0
6.6
umol/l
12.0
14.9
1.17
233
1441
(3034988) Calcium [Moles/volume] in Capillary blood
15
10
15.45
16.75
34.1
1.8
mmol/l
1.2
1.2
—
15
10
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
146
3.91
16.47
37.1
10.1
—
—
—
0
0
(3020891) Body temperature
45
115
4.25
16.18
21.0
4.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
30
55
5.78
15.85
2.1
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
21
26
8.42
15.81
7.4
2.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
245
1582
2.33
15.51
23.9
9.2
e9/l
0.0
0.0
0.50
211
1244
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
14
11.79
15.32
17.2
4.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
198
1176
2.30
15.21
19.2
6.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
37
85
4.66
15.20
2.9
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
77
4.85
15.13
2.1
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
29
54
5.67
15.07
1.7
1.6
—
—
—
0
0
(3010421) pH of Blood
32
66
5.15
14.89
23.1
3.3
ph
7.4
7.4
1.32
23
52
(3020393) Adenovirus Ag [Presence] in Stool
19
23
8.57
14.53
3.3
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
59
196
3.33
14.49
3.0
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
21
29
7.54
14.44
4.5
3.7
%
94.7
92.9
0.08
21
29
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
43
6.09
14.07
2.6
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
27
7.70
14.01
1.6
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
64
233
3.05
13.47
8.0
5.3
%
0.4
0.7
1.00
32
83
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
10
13.33
13.36
2.1
1.1
miu/ml
1725.8
1154.1
—
13
10
(3009508) Creatinine [Moles/volume] in Urine
163
936
2.21
13.13
11.7
3.4
mmol/l
5.5
8.2
18.57
157
806
(3006315) Basophils [#/volume] in Blood
250
1700
2.17
13.01
18.5
6.5
e9/l
0.0
0.0
0.30
234
1430
(3001604) Monocytes [#/volume] in Blood
249
1694
2.16
12.90
18.5
6.5
e9/l
0.6
0.6
1.34
233
1416
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
75
305
2.77
12.89
5.2
2.2
u/l
44.7
29.2
0.98
63
256
(3006653) Thiamine [Moles/volume] in Blood
13
11
12.11
12.62
1.2
1.0
nmol/l
144.8
133.6
0.21
13
11
(3010015) Selenium [Moles/volume] in Serum or Plasma
18
9
20.73
12.53
2.2
3.6
umol/l
1.2
1.0
—
18
9
(3000060) B lymphocytes [#/volume] in Blood
21
35
6.24
12.17
2.8
1.9
e6/l
153.1
620.0
2.36
13
15
(3019198) Lymphocytes [#/volume] in Blood
251
1736
2.12
12.16
18.8
6.5
e9/l
1.9
2.2
2.34
236
1498
(3045414) Leukocytes [Presence] in Urine
38
109
3.72
11.62
5.2
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
250
1744
2.08
11.62
20.7
6.8
e9/l
0.2
0.2
0.48
235
1499
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
56
206
2.97
11.53
3.6
2.4
ug/l
13.8
6.4
1.28
51
176
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
107
548
2.27
11.13
7.7
3.3
ng/l
289.3
428.3
0.45
92
432
(3023419) Bacteria identified in Sputum by Culture
18
28
6.64
11.11
3.4
4.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
267
1927
2.07
11.07
22.8
9.6
e9/l
4.4
3.9
2.56
252
1649
(3000494) Fungus identified in Specimen by Culture
78
348
2.52
11.05
2.5
1.5
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
12
11
11.15
11.05
3.6
3.2
mmol/l
15.7
16.3
0.05
12
11
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
57
217
2.87
11.02
7.7
2.6
ng/l
539.3
164.0
2.07
48
198
(3002179) Metamyelocytes/100 leukocytes in Blood
54
200
2.94
10.97
6.8
5.5
%
0.3
0.4
0.37
20
56
(3051611) Lipemic interference index of Serum or Plasma
21
39
5.59
10.92
7.5
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
217
1462
2.00
10.83
11.9
3.4
estimate
0.0
0.0
0.00
46
246
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
133
754
2.11
10.67
8.2
3.0
ng/l
5793.0
1352.3
3.75
127
638
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
21
40
5.45
10.63
2.8
2.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
52
4.82
10.54
3.1
1.2
—
—
—
0
0
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
10
0
+∞
10.44
6.7
0.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
10
0
+∞
10.44
5.5
0.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
54
206
2.85
10.39
8.2
5.7
%
0.0
0.1
0.68
23
61
(3021601) Nitrite [Presence] in Urine by Test strip
215
1460
1.97
10.33
16.1
4.7
estimate
0.0
0.0
0.00
47
247
(3001186) Copper [Moles/volume] in Serum or Plasma
14
6
23.96
10.28
1.9
1.2
umol/l
16.1
14.4
—
14
6
(3009261) Glucose [Presence] in Urine by Test strip
217
1480
1.97
10.27
11.9
3.5
estimate
0.0
0.0
0.00
47
234
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
132
757
2.08
10.21
4.2
2.5
mg/l
2.9
3.0
0.14
121
654
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
38
5.45
10.15
2.8
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
24
54
4.63
10.08
1.2
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
22
46
4.97
10.06
2.7
2.1
e9/l
1.5
1.7
0.27
13
23
(3013727) Leukocytes other/100 leukocytes in Blood
12
13
9.43
9.86
6.2
5.2
%
47.2
46.9
0.01
12
13
(3021440) Promyelocytes/100 leukocytes in Blood
55
220
2.72
9.67
8.6
5.5
%
0.0
0.2
1.34
30
74
(3000093) Morphology [Interpretation] in Blood Narrative
19
36
5.46
9.66
1.5
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
14
8
17.97
9.44
29.6
1.5
mmol/l
1.2
1.2
—
14
8
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
14
8.76
9.34
18.8
4.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
24
6.42
9.00
5.9
4.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
27
73
3.87
8.97
5.8
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
44
976
0.38
8.71
5.0
2.7
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
22
52
4.39
8.71
16.0
3.4
kpa
10.1
8.1
3.80
22
52
(3012501) Base excess in Blood by calculation
22
52
4.39
8.71
17.9
3.3
mmol/l
1.4
2.5
1.32
12
33
(3013290) Carbon dioxide [Partial pressure] in Blood
22
52
4.39
8.71
17.9
3.4
kpa
4.9
5.0
0.47
22
52
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
40
4.91
8.62
2.8
2.0
%
8.9
7.8
0.16
14
32
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
106
595
2.04
8.49
7.4
2.4
mg/l
4.8
1.7
1.43
93
470
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
11
9.25
8.07
4.8
2.9
ug/l
71.2
176.5
—
10
11
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
32
106
3.17
7.85
32.8
4.8
%
1.7
1.6
0.08
27
96
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
18
40
4.64
7.67
2.5
1.9
e9/l
0.1
0.2
0.27
12
24
(3007930) Methemoglobin/Hemoglobin.total in Blood
31
103
3.16
7.57
33.1
4.9
%
0.9
0.9
0.11
26
95
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
18
41
4.52
7.45
2.5
1.9
e6/l
486.8
572.0
0.22
12
24
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
0
+∞
7.30
2.6
0.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
92
3.18
6.97
1.4
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
104
620
1.89
6.85
2.1
1.5
nmol/l
28.5
20.7
2.35
96
513
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
10
6
16.96
6.76
1.2
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
18
6.22
6.42
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
124
796
1.79
6.39
7.3
3.2
mg/l
907.8
57.1
1.31
116
542
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
15
6.78
6.30
2.4
1.6
u/ml
2879.4
830.8
—
10
15
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
122
2.75
6.16
1.9
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
94
2.99
6.12
1.6
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
50
237
2.25
6.09
3.7
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
27
96
2.93
5.90
1.6
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
9
11.30
5.80
1.7
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
9
11.30
5.80
1.7
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
20
5.60
5.80
1.5
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
20
5.60
5.80
5.9
2.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
12
24
5.10
5.74
1.4
1.2
e6/l
244.7
1404.1
—
7
16
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
24
5.10
5.74
1.4
1.2
e6/l
2641.7
27638.5
—
6
13
(3003694) ABO and Rh group [Type] in Blood
127
843
1.72
5.74
1.7
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
28
4.74
5.73
1.8
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
28
4.74
5.73
1.8
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
28
4.74
5.73
1.8
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
92
2.93
5.73
1.7
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
103
650
1.77
5.54
11.9
5.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
6
13.50
5.08
1.5
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
9
10.14
5.03
2.3
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
9
10.14
5.03
2.3
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
9
10.14
5.03
2.3
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
19
5.34
5.03
1.4
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
246
1974
1.59
5.00
15.5
4.0
e6/l
29.0
720.6
—
8
38
(3000330) Specific gravity of Urine by Test strip
35
155
2.36
4.99
6.8
3.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
271
0.24
4.91
1.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
72
3.00
4.90
1.3
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
71
1113
0.56
4.76
2.2
5.0
ug/l
1.6
2.7
2.15
65
980
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
5
14.14
4.58
1.0
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
233
2739
0.65
4.39
4.9
4.2
mmol/l
6.0
5.9
0.38
224
2487
(3029937) Albumin [Presence] in Urine by Test strip
111
757
1.63
4.38
13.9
3.7
estimate
0.0
0.0
0.00
40
235
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
12
7.60
4.36
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
56
918
0.55
4.33
1.9
4.4
%
25.4
21.2
0.77
23
435
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
6
11.78
4.28
1.0
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
120
842
1.59
4.19
8.3
3.9
mg/mmol
60.0
8.5
3.29
110
559
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
10
326
0.29
4.15
5.2
4.3
%
33.6
30.9
—
10
213
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
32
3.81
4.08
2.2
1.5
—
—
—
0
0
(3013512) EKG study
44
763
0.52
4.07
5.0
3.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
7
10.10
4.01
24.7
5.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
53
3.09
3.97
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
34
3.59
3.76
2.1
2.3
pg
32.0
32.9
0.39
12
34
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
39
3.39
3.76
1.1
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
55
2.97
3.74
4.9
4.1
%
54.4
55.1
0.07
16
55
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
38
666
0.52
3.61
1.7
3.1
ug/l
0.6
0.7
1.23
22
438
(3022621) pH of Urine by Test strip
37
193
2.00
3.57
5.2
2.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
26
3.90
3.51
1.5
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
26
3.90
3.51
1.5
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
266
2997
0.67
3.50
76.8
14.9
%
35.7
39.8
21.74
231
2306
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
6
6
10.07
3.49
1.2
1.2
mg/l
1.8
1.2
—
6
6
(3019309) Folate [Moles/volume] in Red Blood Cells
75
490
1.64
3.46
1.7
1.7
nmol/l
1821.3
1217.7
1.97
67
373
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
53
2.89
3.36
1.1
1.2
u/ml
2.7
3.0
—
7
25
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
53
2.89
3.36
4.8
3.7
e9/l
3.5
4.0
0.79
15
53
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
19
4.79
3.24
1.7
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
138
2.09
3.15
1.7
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
22
98
2.30
3.15
3.5
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
53
325
1.71
3.10
1.5
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
50
2.85
3.09
1.1
1.2
u/ml
3.1
1.5
—
8
16
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
87
2.35
3.02
1.5
1.4
ug/g
339.9
303.9
0.28
12
52
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
21
4.34
2.99
2.1
2.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
30
3.38
2.90
2.4
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
9
6.71
2.86
1.0
2.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
31
3.27
2.77
1.4
1.5
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
5
6
8.38
2.75
1.8
5.7
mg/l
1.2
0.7
—
5
6
(3013336) Amino acids [Identifier] in Serum or Plasma
7
14
5.04
2.73
2.1
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
19
4.25
2.68
2.5
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
15
4.71
2.59
1.0
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
25
3.64
2.57
1.3
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
20
4.04
2.57
2.9
1.7
%
174.9
141.0
—
8
20
(3009871) Measles virus Ab [Titer] in Serum
5
7
7.18
2.54
1.2
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
154
1.87
2.37
1.6
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
8
6.28
2.37
1.0
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
241
2096
1.35
2.29
17.2
3.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
23
3.51
2.27
1.6
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
23
3.51
2.27
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
29
3.13
2.22
4.1
1.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
9
5.58
2.21
2.2
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
9
5.58
2.21
2.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
89
664
1.43
2.21
13.7
3.6
kg/l
1.0
1.0
—
9
107
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
19
3.71
2.15
3.0
1.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
14
4.31
2.15
1.3
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
49
2.48
2.10
5.7
4.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
10
5.02
2.07
2.0
2.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
10
5.02
2.07
2.0
2.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
10
5.02
2.07
2.0
2.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
10
5.02
2.07
2.0
2.7
—
—
—
0
0
(4062490)
10
38
2.66
2.00
1.8
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
112
1.91
1.97
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
27
2.99
1.93
1.4
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
45
2.47
1.92
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
10
39
2.59
1.91
1.1
1.4
—
80.0
—
0
8
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
22
3.20
1.88
1.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
6
17
3.55
1.83
1.3
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
40
2.53
1.83
1.1
1.1
—
—
—
0
0
(4306422)
10
40
2.53
1.83
1.4
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
29
2.78
1.79
1.0
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
15
74
2.06
1.75
60.9
6.4
mmol/l
2.5
1.4
—
10
64
(3043410) Blood group antigens tested for on Red Blood Cells
5
13
3.86
1.71
4.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
20
3.01
1.58
1.3
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
26
2.71
1.58
1.3
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
33
2.44
1.53
1.4
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
15
3.34
1.52
2.0
2.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
15
3.34
1.52
1.2
2.8
nmol/l
226.8
97.5
—
5
15
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
21
2.87
1.50
4.5
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
132
1106
1.28
1.49
2.2
1.9
pmol/l
90.9
95.0
0.39
62
566
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
22
2.74
1.43
1.8
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
40
2.27
1.40
1.7
1.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
41
2.21
1.37
3.3
2.5
mmol/l
4.8
4.1
—
9
41
(3035285) Chloride [Moles/volume] in Venous blood
9
41
2.21
1.37
3.3
2.5
mmol/l
107.4
105.0
—
9
41
(4268621)
9
41
2.21
1.37
2.3
2.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
17
2.95
1.35
1.4
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
47
2.15
1.33
2.3
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
47
2.15
1.33
1.3
1.1
—
—
—
0
0
(4034850)
16
90
1.80
1.33
7.7
9.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
94
765
1.29
1.33
2.2
1.7
mmol/l
1.7
1.3
2.00
94
658
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
36
2.24
1.24
2.6
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
25
2.41
1.24
1.2
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
37
2.17
1.21
3.4
3.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
37
2.17
1.21
2.0
3.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
33
0.00
1.16
0.0
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
451
0.70
1.13
1.4
1.3
u/ml
6.8
13.2
0.68
17
163
(40761511) CBC panel - Blood by Automated count
312
3264
0.80
1.11
52.3
11.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
121
0.49
1.07
1.3
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
274
0.64
1.06
1.4
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
74
1.77
1.06
2.9
3.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
5
22
2.28
1.03
2.8
2.1
ml
719.4
518.1
—
5
15
(3008898) HLA-B27 [Presence]
7
134
0.51
1.00
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
36
473
0.73
0.98
1.3
1.2
iu/ml
43.3
33.2
0.29
12
144
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
36
1.95
0.97
1.0
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
26
182
1.45
0.96
1.3
2.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
31
0.00
0.96
0.0
1.1
—
8.0
—
0
20
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
325
0.69
0.96
1.5
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
145
0.54
0.94
1.1
2.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
50
393
1.30
0.94
1.3
1.4
titre
408.9
478.4
—
9
73
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
27
2.23
0.93
1.0
1.0
mg/l
259.8
302.0
—
6
22
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
432
0.74
0.89
1.8
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
42
1.91
0.89
4.0
4.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
30
2.01
0.87
1.0
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
45
1.78
0.84
1.1
1.1
u/l
13.9
13.3
—
8
36
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
154
1.45
0.83
2.6
2.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
46
1.75
0.82
1.1
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
32
1.88
0.81
1.0
1.5
nmol/l
—
—
—
0
0
(4010399)
15
222
0.66
0.81
1.3
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
8
47
1.71
0.80
1.1
1.1
—
11.4
—
0
10
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
115
1011
1.18
0.79
5.2
3.3
ng/l
377.9
76.2
0.55
101
689
(4146454)
0
26
0.00
0.78
0.0
2.7
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.3
—
40.4
—
0
5
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
119
1050
1.18
0.78
2.3
2.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.76
1.0
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
59
1.70
0.75
2.0
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
24
2.09
0.74
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
24
2.09
0.74
1.6
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
24
2.09
0.74
1.6
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
24
2.09
0.74
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
24
2.09
0.74
1.6
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
38
1.85
0.73
1.0
1.4
nmol/l
0.5
0.5
—
7
33
(3023410) Appearance of Cerebral spinal fluid
9
55
1.64
0.73
3.7
3.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
108
1.49
0.73
1.5
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
25
2.00
0.72
3.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
25
2.00
0.72
1.6
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
25
2.00
0.72
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
92
1.53
0.72
1.5
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
327
1.28
0.72
12.9
6.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
41
1.71
0.70
4.0
2.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
58
1.56
0.70
1.2
1.2
—
1.1
—
0
6
(40760888) Immunoglobulin light chains.free panel - Serum
9
58
1.56
0.70
1.2
4.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
179
0.66
0.69
1.7
2.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
178
0.66
0.67
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
22
291
0.74
0.66
2.0
4.5
ug/l
126.9
31.9
0.35
17
247
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
212
0.69
0.66
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
78
1.55
0.65
1.5
2.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
64
544
1.20
0.65
2.0
1.7
pmol/l
539.0
21508207.3
0.79
64
451
(3007164) IgA [Mass/volume] in Serum or Plasma
91
799
1.17
0.64
1.9
1.5
g/l
2.1
2.2
0.38
68
439
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
29
1.72
0.63
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
187
0.68
0.63
1.2
1.2
iu/ml
9.2
146.6
—
7
61
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
64
739
0.84
0.63
1.9
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
123
1107
1.15
0.63
13.8
3.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
13
87
1.50
0.63
3.0
2.9
e6/l
1.3
3.6
—
8
61
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
13
87
1.50
0.63
3.0
3.0
e6/l
397.6
230.6
—
8
63
(3022145) Colonoscopy Study observation
37
298
1.26
0.61
1.2
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
2.0
2.7
nmol/l
12.4
3.5
—
5
30
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
214
2004
1.13
0.59
4.6
3.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
312
3207
0.87
0.55
65.6
12.5
mg/l
26.3
26.5
0.04
296
2431
(3003740) Influenza virus B Ag [Presence] in Specimen
10
65
1.54
0.55
2.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
60
1.50
0.54
1.6
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
60
1.50
0.54
1.2
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
66
1.52
0.52
2.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
294
0.80
0.44
1.7
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
94
0.63
0.42
3.2
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
12.0
—
9.7
—
0
15
(3005011) Chlamydia sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
16
0.00
0.41
0.0
1.1
—
7.5
—
0
16
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
101
0.68
0.40
3.6
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
76
833
0.89
0.39
1.3
1.5
u/ml
1.4
1.3
0.04
22
184
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
67
1.34
0.38
1.2
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
11
80
1.38
0.38
1.2
3.5
—
3.1
—
0
7
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
9
68
1.32
0.37
3.1
2.7
ug/min
686.4
79.2
—
9
46
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
70
1.29
0.36
1.2
1.2
—
2.7
—
0
10
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
70
1.29
0.36
1.2
1.2
—
9.6
—
0
13
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
91
1.32
0.33
1.6
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
17
136
1.25
0.33
1.5
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
127
1.26
0.33
1.6
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
212
2189
0.93
0.31
4.3
3.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
62
1.29
0.28
1.3
1.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
64
1.25
0.27
1.3
1.2
—
46.6
—
0
6
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
127
0.78
0.26
2.5
2.3
u/l
51.9
41.9
—
10
115
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
113
1.24
0.26
1.9
1.3
u/ml
0.2
2.9
—
9
76
(3019225) pH of Specimen
19
223
0.84
0.26
28.1
3.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
141
1.21
0.25
1.5
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
142
1.20
0.24
1.5
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
37
1.35
0.23
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
143
1.19
0.22
1.5
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
40
1.25
0.22
2.2
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
11
0.00
0.21
0.0
10.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
123
0.80
0.21
1.3
1.1
—
—
—
0
0
(4211845)
0
12
0.00
0.21
0.0
4.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
12
0.00
0.21
0.0
4.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
6.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
98
1.23
0.20
1.7
2.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
114
0.78
0.20
1.1
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
67
0.74
0.17
1.2
2.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
120
1.17
0.16
2.2
2.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
75
0.79
0.15
1.3
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
82
779
1.06
0.15
12.3
3.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
264
2664
0.96
0.12
38.3
12.1
ml/min/173m2
64.8
83.0
7.60
230
2110
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
181
1.10
0.11
1.2
1.3
—
45.0
—
0
14
(3027008) Opiates [Presence] in Urine
16
143
1.12
0.11
1.3
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
114
0.87
0.10
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
237
0.92
0.10
14.8
3.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
47
1.06
0.09
1.6
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
45
427
1.06
0.09
3.6
3.0
ug/g
275.8
118.9
1.10
39
347
(3032773) Endomysium IgG Ab [Titer] in Serum
6
53
1.13
0.09
1.0
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.0
g/l
1.7
1.5
—
6
48
(3000492) Spirometry study
24
256
0.93
0.09
1.7
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
64
0.78
0.08
1.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
63
1.11
0.08
1.3
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
40
380
1.05
0.08
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
70
0.85
0.07
1.8
1.3
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
6
70
0.85
0.07
1.0
1.0
kpa
3.2
3.3
—
6
59
(3006598) pH of Arterial cord blood
6
71
0.84
0.07
1.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
6
71
0.84
0.07
1.0
1.0
kpa
8.3
7.6
—
6
60
(1761482) Bacteria [#/volume] in Urine by Culture
8
77
1.03
0.07
4.9
4.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
303
0.95
0.06
1.4
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
33
322
1.02
0.01
1.2
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
20.5
—
0
7
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
9.6
—
0
5
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(4015189)
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
4.2
—
3092.0
—
0
6
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_DEPENDENCE_ENABL_MACHINES_DEVICES_NOT_ELSEW_CLASSIFIED – Dependence on enabling machines and devices, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).